-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $100

Benzinga·11/06/2026 14:46:02
Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $99 to $100.